We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Queen Alexandra Hospital Opens Fecal Bank

By HospiMedica International staff writers
Posted on 31 May 2016
Print article
Image: Clostridium difficile in a Petri dish (Photo courtesy of the University of Portsmouth).
Image: Clostridium difficile in a Petri dish (Photo courtesy of the University of Portsmouth).
Queen Alexandra Hospital (Portsmouth, United Kingdom) has opened a new frozen fecal bank, which could help cure for infections caused by Clostridium difficile.

The bank is part of a pilot project run by Robert Porter, MD, a consultant in microbiology and infection at Portsmouth Hospitals' NHS Trust (Portsmouth, United Kingdom). The bank will give patients across the United Kingdom access to screened frozen fecal material from a healthy donor in order to deliver healthy bacteria into the gut of a patient suffering from severe C. difficile infection.

The frozen samples, collected from pre-screened volunteers, can be stored for up to three months, and can be transported anywhere in the United Kingdom within hours, using overnight cold storage delivery; a single fecal transplant from the bank will cost about £85. The bank is funded by the Wessex Academic Health Science Network (Southhampton, United Kingdom), and supported by senior lecturer and researcher Carole Fogg, PhD, of the University of Portsmouth (Portsmouth, United Kingdom).

“Fecal transplants are extremely successful, and the impact on people's lives of such a simple treatment is difficult to overstate,” said Dr. Porter. “This is about something we all do every day potentially saving other people's lives. The pilot bank service also opens doors to new research, which we fully intend to take forward.”

Clostridium difficile is a bacterium that causes infection leading to diarrhea, and is most often related to antibiotic use during medical treatment. It is especially dangerous for patients with weakened immune systems such as the elderly and those with inflammatory bowel disease (IBD). Treatment includes antibiotics, probiotics, toxin-binding medications, active vaccination, and intravenous immunoglobon. About 20% of patients are resistant to these treatment and need a fecal microbiota transplant, which has a 96% cure rate.

Related Links:
Queen Alexandra Hospital
Portsmouth Hospitals' NHS Trust
Wessex Academic Health Science Network
University of Portsmouth
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Examination Data Management Software
DiVAS 2.8

Print article

Channels

Critical Care

view channel
Image: The stretchable microneedle electrode arrays (Photo courtesy of Zhao Research Group)

Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment

The field of personalized medicine is transforming rapidly, with advancements like wearable devices and home testing kits making it increasingly easy to monitor a wide range of health metrics, from heart... Read more

Surgical Techniques

view channel
Image: NeuroBlate NB3 FullFire 1.6mm laser probe is meant for use with the NeuroBlate System (Photo courtesy of Monteris Medical)

World’s Smallest Laser Probe for Brain Procedures Facilitates Ablation of Full Range of Targets

A new probe enhances the ablation capabilities for a broad spectrum of oncology and epilepsy targets, including pediatric applications, by incorporating advanced laser and cooling technologies to support... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more